Literature DB >> 23999797

Metal-free transannulation reaction of indoles with nitrostyrenes: a simple practical synthesis of 3-substituted 2-quinolones.

Alexander V Aksenov1, Alexander N Smirnov, Nicolai A Aksenov, Inna V Aksenova, Liliya V Frolova, Alexander Kornienko, Igor V Magedov, Michael Rubin.   

Abstract

3-Substituted 2-quinolones are obtained via a novel, metal-free transannulation reaction of 2-substituted indoles with 2-nitroalkenes in polyphosphoric acid. The reaction can be used in conjunction with the Fisher indole synthesis offering a practical three-component heteroannulation methodology to produce 2-quinolones from arylhydrazines, 2-nitroalkenes and acetophenone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23999797      PMCID: PMC4945960          DOI: 10.1039/c3cc45696j

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  18 in total

Review 1.  Practical methodologies for the synthesis of indoles.

Authors:  Guy R Humphrey; Jeffrey T Kuethe
Journal:  Chem Rev       Date:  2006-07       Impact factor: 60.622

2.  3-Aryl-4-methyl-2-quinolones targeting multiresistant Staphylococcus aureus bacteria.

Authors:  Anne Doléans-Jordheim; Jean-Baptiste Veron; Olivier Fendrich; Emmanuelle Bergeron; Adrien Montagut-Romans; Yung-Sing Wong; Bianca Furdui; Jean Freney; Charles Dumontet; Ahcène Boumendjel
Journal:  ChemMedChem       Date:  2013-02-21       Impact factor: 3.466

3.  Facile and efficient synthesis of quinolin-2(1H)-ones via cyclization of penta-2,4-dienamides mediated by H2SO4.

Authors:  Xu Liu; Xin Xin; Dexuan Xiang; Rui Zhang; Santosh Kumar; Fenguo Zhou; Dewen Dong
Journal:  Org Biomol Chem       Date:  2012-06-25       Impact factor: 3.876

4.  An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.

Authors:  David Beattie; David Beer; Michelle E Bradley; Ian Bruce; Steven J Charlton; Bernard M Cuenoud; Robin A Fairhurst; David Farr; John R Fozard; Diana Janus; Elizabeth M Rosethorne; David A Sandham; David A Sykes; Alexandre Trifilieff; Katharine L Turner; Elke Wissler
Journal:  Bioorg Med Chem Lett       Date:  2012-08-04       Impact factor: 2.823

5.  Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.

Authors:  Sun-Young Han; Jie Won Choi; Jeon Yang; Chong Hack Chae; Jongkook Lee; Heejung Jung; Kwangho Lee; Jae Du Ha; Hyoung Rae Kim; Sung Yun Cho
Journal:  Bioorg Med Chem Lett       Date:  2012-03-07       Impact factor: 2.823

6.  Elucidation of structure-activity relationship of 2-quinolone derivatives and exploration of their antitumor potential through Bax-induced apoptotic pathway.

Authors:  Nitesh Kumar; Vasanth P Raj; B S Jayshree; Sidhartha S Kar; Arvind Anandam; Seeja Thomas; Prateek Jain; Amita Rai; C M Rao
Journal:  Chem Biol Drug Des       Date:  2012-06-06       Impact factor: 2.817

Review 7.  Heterocycles as nonclassical bioisosteres of α-amino acids.

Authors:  Christian B M Poulie; Lennart Bunch
Journal:  ChemMedChem       Date:  2013-01-15       Impact factor: 3.466

8.  4H-1,2-benzoxazines with electron-withdrawing substituents on the benzene ring: synthesis and application as potent intermediates for oxygen-functionalized aromatic compounds.

Authors:  Satoshi Nakamura; Masanobu Uchiyama; Tomohiko Ohwada
Journal:  J Am Chem Soc       Date:  2003-05-07       Impact factor: 15.419

9.  Cascade palladium-catalyzed alkenyl aminocarbonylation/ intramolecular aryl amidation: an annulative synthesis of 2-quinolones.

Authors:  Andrew C Tadd; Ai Matsuno; Mark R Fielding; Michael C Willis
Journal:  Org Lett       Date:  2009-02-05       Impact factor: 6.005

10.  Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery.

Authors:  Prasad V Chaturvedula; Stephen E Mercer; Sokhom S Pin; George Thalody; Cen Xu; Charlie M Conway; Deborah Keavy; Laura Signor; Glenn H Cantor; Neil Mathias; Paul Moench; Rex Denton; Robert Macci; Richard Schartman; Valerie Whiterock; Carl Davis; John E Macor; Gene M Dubowchik
Journal:  Bioorg Med Chem Lett       Date:  2013-04-12       Impact factor: 2.823

View more
  5 in total

1.  Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells.

Authors:  Alexander V Aksenov; Alexander N Smirnov; Igor V Magedov; Mary R Reisenauer; Nicolai A Aksenov; Inna V Aksenova; Alexander L Pendleton; Gina Nguyen; Robert K Johnston; Michael Rubin; Annelise De Carvalho; Robert Kiss; Véronique Mathieu; Florence Lefranc; Jaime Correa; David A Cavazos; Andrew J Brenner; Brad A Bryan; Snezna Rogelj; Alexander Kornienko; Liliya V Frolova
Journal:  J Med Chem       Date:  2015-02-20       Impact factor: 7.446

Review 2.  Isolation and synthesis of cryptosanguinolentine (isocryptolepine), a naturally-occurring bioactive indoloquinoline alkaloid.

Authors:  Elida N Thobokholt; Enrique L Larghi; Andrea B J Bracca; Teodoro S Kaufman
Journal:  RSC Adv       Date:  2020-05-19       Impact factor: 4.036

Review 3.  Recent Advances in One-Pot Modular Synthesis of 2-Quinolones.

Authors:  Wan Pyo Hong; Inji Shin; Hee Nam Lim
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

4.  Electrophilic alkylation of arenes with 5-bromopyrimidine en route to 4-aryl-5-alkynylpyrimidines.

Authors:  Stanislav S Shcherbakov; Artyom Yu Magometov; Viktoriia Yu Shcherbakova; Alexander V Aksenov; Dmitriy A Domenyuk; Vladimir A Zelensky; Michael Rubin
Journal:  RSC Adv       Date:  2020-03-10       Impact factor: 3.361

5.  Improved Method for Preparation of 3-(1H-Indol-3-yl)benzofuran-2(3H)-ones.

Authors:  Igor Yu Grishin; Nikolai A Arutiunov; Dmitrii A Aksenov; Nicolai A Aksenov; Alexander V Aksenov; Amina Z Gasanova; Elena A Sorokina; Carolyn Lower; Michael Rubin
Journal:  Molecules       Date:  2022-03-15       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.